<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two patients with hypergranular <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> are presented: they represent 1.4% of patients with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> studied and treated in a single institution in the past 12 years </plain></SENT>
<SENT sid="1" pm="."><plain>This frequency is substantially lower than that reported in Caucasian populations </plain></SENT>
<SENT sid="2" pm="."><plain>The blast cells of the patients disclosed an early-B phenotype, displaying CD45, CD10 and CD19 antigens </plain></SENT>
<SENT sid="3" pm="."><plain>The cytoplasmic granules were positive for the <z:chebi fb="61" ids="27565">PAS</z:chebi> reaction </plain></SENT>
<SENT sid="4" pm="."><plain>Both patients died early after starting treatment; a poor prognosis has been recorded previously for patients with this type of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>